NSE · Healthcare · Drug Manufacturers - Specialty & Generic
EPS came in at 31.20 against a street estimate of 4.50 — a beat of 593.3%.
with an average price target of ₹450.00.
| Document | Date |
|---|---|
| Quarterly results · Q1 FY27 WOCKHARDT LIMITED - Q1 FY27 RESULTS SUMMARY HEADLINE NUMBERS • Profit After Tax (PAT): Rs. 107 Cr in Q1 FY27 vs Rs. (108) Cr loss in Q1 FY26 – signi | 2026-08-10 |
| Annual report FY2026 WOCKHARDT LIMITED – SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • 27th Annual General Meeting scheduled for Monday, August 10, 2026 at 3:30 p.m. I | 2026-07-17 |
| Q4 FY26 earnings call WOCKHARDT LIMITED - INVESTOR MEETING SUMMARY June 4, 2026 --- HEADLINE NUMBERS • Revenue (FY2026): INR 3,373 crores • EBITDA: INR 630 crores with 5 | 2026-06-11 |
| Investor presentation · Q4 FY26 WOCKHARDT LIMITED – INVESTOR PRESENTATION SUMMARY 4 June 2026 --- HEADLINE NUMBERS • FY26 Revenue (Income): INR 3,373 Crore • FY26 EBITDA: INR 630 | 2026-06-04 |
| Quarterly results · Q4 FY26 WOCKHARDT LIMITED - FINANCIAL RESULTS SUMMARY (FY 2025-26) HEADLINE NUMBERS • Profit Before Tax (PBT) FY26: Rs. 238 Cr (vs Rs. -16 Cr loss in FY25) | 2026-05-04 |
| Quarterly results · Q3 FY26 WOCKHARDT LIMITED – Q3 FY2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Q3 Revenue: Rs.888 crore, up 22% year-on-year (vs Rs.725 crore in Q3 FY25) • Q3 E | 2026-02-10 |
| Quarterly results · Q2 FY26 WOCKHARDT LIMITED – FINANCIAL RESULTS SUMMARY HEADLINE NUMBERS • Q2 FY2025-26 (Quarter ended Sept 30, 2025) – STANDALONE: - Revenue from operation | 2025-11-03 |
| Quarterly results · Q1 FY26 WOCKHARDT LIMITED – Q1 FY26 RESULTS SUMMARY HEADLINE NUMBERS • Revenue: INR 738 Cr in Q1 FY26 vs INR 747 Cr in Q1 FY25 (down 1.2% YoY) • EBITDA: INR | 2025-08-08 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Wockhardt Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.